MarketsandMarkets Presents Availability of User-Friendly Aesthetic Devices will help to grow the Medical Aesthetics Market

The report "Medical Aesthetics Market by Product (Liposuction, Cellulite & Fat Reduction, Skin Tightening, Breast Implants, Botox, Dermal Fillers, Tattoo Removal, Thread Lift, Laser Hair Removal), End-User (Clinics & Medical Spas, Beauty Center) - Forecast to 2021“Medical Aesthetics Market Browse 70 market data tables and 38 figures spread through 173 pages and in- depth TOC on “Medical Aesthetics Market by Product (Liposuction, Cellulite & Fat Reduction, Skin Tightening, Breast Implants, Botox, Dermal Fillers, Tattoo Removal, Thread Lift, Laser Hair Removal), End-User (Clinics & Medical Spas, Beauty Center) - Forecast to 2021”

Early buyers will receive 10% customization on this report.

Medical aesthetics devices are used to improve the cosmetic appearance through the treatment of conditions such as liver spots, excess fat, scars, skin laxity, wrinkles, moles, cellulite, unwanted hair, spider veins, and skin discoloration. The global Medical aesthetics market is estimated to grow at a CAGR of 10.8% from 2016 to 2021 to reach USD Billion by Key factors such as the growing adoption of non-invasive procedures, growth in aging population, increasing awareness among customers, technological advancements in energy-based medical aesthetics devices, and increasing demand for aesthetic treatments among the male population are driving the growth of the aesthetic devices market. However, stringent safety regulations for aesthetic procedures, social stigma associated with cosmetic treatments, and low focus of market players on developing medical aesthetic devices for dermatological conditions are restraining the growth of this market.

Based on product, the medical aesthetics market is categorized into energy- based devices, breast implants, facial aesthetics, tattoo removal, physician- dispensed cosmeceuticals and skin lighteners, physician-dispensed eyelash products, thread lifting, laser resurfacing devices, and laser hair removal. The facial aesthetics segment is expected to account for the largest share of the medical aesthetics market in The large share of this segment can be attributed to the growing patient demand for facial aesthetic treatments, increasing demand of non-invasive cosmetic procedures, launch of new products, and growth in aging population. On the basis of end user, the market is segmented into clinics plus medical spas and beauty centres. The clinics and medical spas segment is estimated to register the higher CAGR from 2016 to The high growth of this segment is primarily attributed to the growing number of clinics and medical spas and increasing number of skilled professionals to perform the aesthetic procedures, rapidly increasing aging and obese population across the globe, increasing preference for minimally invasive and non-invasive aesthetic procedures.

By product, the western blotting market is categorized into consumables and instruments. The consumables segment is expected to command the largest share of the global western blotting market, by product in This is attributed to factors such as increasing use of western blotting in research & diagnosis and rising incidence of diseases that require western blotting for diagnosis. The western blotting instruments are further segmented into gel electrophoresis instruments, blotting systems, and imagers. The blotting systems segment is expected to account for the largest share of the western blotting instruments market, by type in The semi-dry blotting systems are expected to command the largest share of blotting systems market, by type and are likely to grow at the highest CAGR during the forecast period. The largest share of this segment is attributed to high sensitivity, low run time, and high efficiency.

On the basis of application, the global western blotting market is segmented biomedical & biochemical research, disease diagnostics, agriculture and others (biologics and quality control). The biomedical & biochemical research segment is expected to account for the largest share of the global western blotting market, by application in This can be attributed to the rising government spending in proteomics research, and increased R&D spending by pharmaceutical & biotechnology companies in drug discovery and development. However, the disease diagnostics segment is projected to grow at the highest CAGR from 2016 to This can be attributed rising prevalence and incidences of HIV, HSV, HBV, and Lyme disease, among others. On the basis of end user, the western blotting market is segmented into academic & research institutes, pharmaceutical & biotechnology companies, diagnostic centers and others (CROs, food & beverage companies and forensic laboratories). In 2016, the academic & research institutes segment is expected to command the largest share of the global western blotting market, by end user. This can be attributed to the increasing research activities in the academic institutes backed by government funding and HIV initiatives by various governments across the globe. However, the disease diagnostics segment is projected to grow at the highest CAGR from 2016 to 2021.

On the basis of region, the global market is divided into North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, North America is poised to account for the largest share of the western blotting market, followed by Europe and Asia-Pacific. However, the Asia-Pacific market is slated to grow at the highest CAGR during the forecast period. Factors such as development of bioclusters in China and India, growing pharmaceutical and biotechnology sector in Japan, growing funding for agriculture research in India, increasing government interest in biomedical & biotechnology industry in China, increasing diagnosis and related funding for HIV in Australia, and growing prevalence of HSV in south east Asia are expected to propel the growth of the western blotting market in the Asia-Pacific region.

Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), GE Healthcare (U.S.), Advansta, Inc. (U.S.), LI-COR Biosciences (U.S.), PerkinElmer, Inc. (U.S.), Bio-Techne Corporation (U.S.), Merck KGaA (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), and Cell Signaling Technology, Inc. (U.S.) are some of the key players in the western blotting market worldwide.

Contact Us Contact: Mr. Shelly Singh Markets and Markets UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar Pune, Maharashtra , India

About MarketsandMarkets MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. They cover thirteen industry verticals, including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT. We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.